Korean Stock Flows

HLB Life Science (KRX: 067630)

HLB생명과학 KOSDAQ Biotech & Pharma 의료용품 및 기타 의약 관련제품 제조업
Close (Oct 13, 2026)
₩3,920
-3.21%
Market cap
₩0T ($0.4B)
52-week range
₩1,608 – ₩5,330
P/E (trailing) · P/B · Div yield
– · 1.61 · 0%

Who is buying HLB Life Science?

Between Sep 10, 2026 and Oct 13, 2026 (20 trading sessions), foreign investors net bought ₩0.6bn ($0M) of HLB Life Science, the 213th largest foreign net purchase among 1828 KOSDAQ stocks. Institutions net sold ₩0.3bn ($0M) and retail investors net sold ₩0.2bn ($0M) over the same window. Foreigners were net buyers on 10 of the 20 sessions.

Foreign investors hold 5.93% of HLB Life Science's listed shares (KRX ownership data as of Oct 13, 2026), up from 5.31% twenty sessions earlier and 9.64% a year ago.

The stock closed at ₩3,920 on Oct 13, 2026: +58.06% over 20 sessions, +1.16% year-to-date, +17.54% over one year. The 52-week range is ₩1,608 – ₩5,330.

HLB Life Science share price, last 60 trading days (KRW)
4,693 3,618 2,542 1,467 Jul 13 Aug 26 Oct 13
Daily foreign investor net purchases, last 60 trading days
+1bn +0.5bn -0.5bn -1bn Jul 13 Aug 26 Oct 13
View chart data as a table
Date Close Foreign net Institutions Retail
2026-10-13 ₩3,920 ₩-0.7bn +₩0.0bn +₩0.7bn
2026-10-12 ₩4,050 +₩0.1bn +₩0.0bn ₩-0.1bn
2026-10-08 ₩4,520 +₩0.1bn ₩0.0bn ₩-0.1bn
2026-10-07 ₩4,185 +₩0.0bn +₩0.0bn ₩-0.1bn
2026-10-06 ₩4,470 +₩0.9bn ₩-0.0bn ₩-0.8bn
2026-10-02 ₩3,575 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-10-01 ₩3,715 ₩-0.5bn ₩0.0bn +₩0.5bn
2026-09-30 ₩3,930 +₩1.0bn +₩0.0bn ₩-1.0bn
2026-09-29 ₩3,630 +₩0.2bn ₩-0.3bn +₩0.2bn
2026-09-28 ₩3,405 ₩-0.0bn ₩-0.0bn ₩-0.0bn
2026-09-23 ₩2,620 ₩-0.0bn ₩0.0bn +₩0.0bn
2026-09-22 ₩2,625 +₩0.1bn ₩-0.0bn ₩-0.1bn
2026-09-21 ₩2,675 ₩-0.3bn ₩0.0bn +₩0.3bn
2026-09-18 ₩2,405 ₩-0.2bn ₩0.0bn +₩0.2bn
2026-09-17 ₩2,550 ₩-0.0bn ₩0.0bn +₩0.0bn
2026-09-16 ₩2,600 +₩0.0bn ₩0.0bn ₩-0.0bn
2026-09-15 ₩2,595 ₩-0.0bn ₩0.0bn +₩0.0bn
2026-09-14 ₩2,465 +₩0.1bn ₩0.0bn ₩-0.1bn
2026-09-11 ₩2,515 ₩-0.0bn ₩0.0bn +₩0.0bn
2026-09-10 ₩2,550 +₩0.0bn ₩0.0bn ₩-0.0bn
2026-09-09 ₩2,480 +₩0.0bn ₩0.0bn ₩-0.0bn
2026-09-08 ₩2,530 ₩-0.1bn ₩-0.0bn +₩0.1bn
2026-09-07 ₩2,660 ₩-0.0bn ₩0.0bn +₩0.0bn
2026-09-04 ₩2,685 +₩0.1bn ₩0.0bn ₩-0.1bn
2026-09-03 ₩2,630 +₩0.0bn ₩0.0bn ₩-0.0bn
2026-09-02 ₩2,660 ₩-0.0bn ₩0.0bn +₩0.0bn
2026-09-01 ₩2,740 ₩-0.4bn ₩0.0bn +₩0.4bn
2026-08-31 ₩2,700 ₩-0.1bn ₩0.0bn +₩0.1bn
2026-08-28 ₩2,645 +₩0.0bn ₩0.0bn ₩-0.0bn
2026-08-27 ₩2,640 ₩-0.2bn ₩0.0bn +₩0.2bn
2026-08-26 ₩2,745 ₩-0.0bn ₩0.0bn +₩0.0bn
2026-08-25 ₩2,790 ₩-0.0bn ₩0.0bn +₩0.0bn
2026-08-24 ₩2,815 ₩-0.1bn ₩0.0bn +₩0.1bn
2026-08-21 ₩2,940 +₩0.1bn ₩0.0bn ₩-0.1bn
2026-08-20 ₩3,035 ₩-0.2bn ₩0.0bn +₩0.2bn
2026-08-19 ₩3,105 +₩0.1bn ₩0.0bn ₩-0.1bn
2026-08-18 ₩3,200 +₩0.1bn ₩0.0bn ₩-0.1bn
2026-08-14 ₩3,160 ₩-0.2bn ₩0.0bn +₩0.2bn
2026-08-13 ₩3,080 +₩0.1bn ₩0.0bn ₩-0.1bn
2026-08-12 ₩2,915 +₩0.0bn ₩0.0bn ₩-0.0bn
2026-08-11 ₩2,880 +₩0.1bn ₩0.0bn ₩-0.1bn
2026-08-10 ₩2,715 +₩0.4bn ₩0.0bn ₩-0.3bn
2026-08-07 ₩2,500 +₩0.2bn ₩0.0bn ₩-0.2bn
2026-08-06 ₩2,365 +₩0.1bn ₩0.0bn ₩-0.1bn
2026-08-05 ₩2,290 +₩0.1bn ₩0.0bn ₩-0.1bn
2026-08-04 ₩2,170 +₩0.2bn ₩0.0bn ₩-0.2bn
2026-08-03 ₩2,055 +₩0.1bn ₩0.0bn ₩-0.1bn
2026-07-31 ₩2,020 +₩0.1bn ₩0.0bn ₩-0.1bn
2026-07-30 ₩1,925 ₩-0.2bn ₩0.0bn +₩0.2bn
2026-07-29 ₩2,020 ₩-0.1bn ₩0.0bn +₩0.1bn
2026-07-28 ₩2,035 ₩-0.0bn ₩0.0bn +₩0.0bn
2026-07-27 ₩2,200 ₩-0.0bn ₩0.0bn +₩0.0bn
2026-07-24 ₩2,205 ₩-0.1bn ₩0.0bn +₩0.1bn
2026-07-23 ₩2,045 ₩-0.1bn ₩0.0bn +₩0.1bn
2026-07-22 ₩1,967 ₩-0.1bn ₩0.0bn +₩0.1bn
2026-07-21 ₩2,045 ₩-0.2bn ₩0.0bn +₩0.2bn
2026-07-20 ₩2,105 ₩-0.0bn ₩0.0bn +₩0.0bn
2026-07-16 ₩2,380 ₩-0.4bn ₩-0.0bn +₩0.4bn
2026-07-15 ₩2,325 ₩-0.1bn +₩0.0bn +₩0.1bn
2026-07-14 ₩1,791 +₩0.4bn ₩0.0bn ₩-0.4bn
2026-07-13 ₩1,640 ₩-0.0bn ₩0.0bn ₩-0.1bn

Investor flows summary

Window Foreign (USD) Institutions Retail
1 day ₩-0.7bn $-0M +₩0.0bn +₩0.7bn
5 days +₩0.4bn +$0M +₩0.0bn ₩-0.3bn
20 days +₩0.6bn +$0M ₩-0.3bn ₩-0.2bn

Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.

Frequently asked questions

Are foreign investors buying HLB Life Science stock?

Over the last 5 sessions foreign investors net bought ₩0.4bn ($0M) of HLB Life Science; over 60 sessions they net bought ₩0.1bn ($0M); since Jan 1, 2026 they net sold ₩8.7bn ($7M). Over 20 sessions the stock is the 213th largest foreign net purchase among 1828 KOSDAQ stocks.

How much of HLB Life Science do foreign investors own?

Foreign investors own 5.93% of HLB Life Science's shares as of Oct 13, 2026, versus 9.64% one year earlier. The figure is KRX's daily foreign holdings divided by listed shares, and it reflects trades settled through the previous session.

Who is on the other side — institutions or retail investors?

Over 20 sessions institutions net sold ₩0.3bn ($0M) and retail investors net sold ₩0.2bn ($0M) of HLB Life Science. Foreign buying is being met mainly by retail selling.

Is HLB Life Science listed on KOSPI or KOSDAQ?

HLB Life Science (HLB생명과학) trades on KOSDAQ under KRX code 067630 in the Biotech & Pharma group, with a market capitalization of ₩0T ($0.4B). Daily net flows by investor type are published by KRX after each session and combine the KRX main board with the NXT venue.

Annual financials

Fiscal year Revenue YoY Operating profit Net income
2023 ₩98bn ($74M) – -₩25bn (-$18M) -₩6bn (-$4M)
2024 ₩102bn ($77M) +4.30% -₩25bn (-$19M) ₩6bn ($5M)
2025 ₩46bn ($34M) -55.30% -₩22bn (-$17M) -₩100bn (-$75M)

Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1333.09/$) for reference only.

← All foreign investor flows